Oxytocin Peptide Rescues Impaired Maternal Behavior in Dogs With an Autism-Linked Gene Mutation

Shank3 mutant mother dogs exhibited significantly fewer and shorter licking bouts and reduced nursing frequency compared to wild-type dams. Blood oxytocin concentrations were significantly decreased in mutant dams. A two-week vehicle-controlled intranasal oxytocin treatment, starting on postpartum day 8, significantly rescued the licking behavior deficits both acutely and chronically. This demonstrates that the maternal behavior impairments in these autism-model dogs are at least partly driven by oxytocin system dysfunction.

Researchers generated Shank3 mutant domestic dogs using CRISPR/Cas9 gene editing. Maternal behaviors (licking frequency, licking duration, nursing frequency) were quantified in mutant and wild-type dams with their puppies. Blood oxytocin levels were measured. A vehicle-controlled experiment tested two weeks of intranasal oxytocin treatment beginning on postpartum day 8, with both acute and chronic behavioral assessments.

Most autism research uses mice, but dogs are far more socially complex and may better model human social behavior deficits. This study validates Shank3-mutant dogs as a new large-animal autism model and provides compelling evidence that oxytocin can rescue specific social behavior deficits caused by this genetic mutation. The finding that both acute and chronic oxytocin treatment worked is particularly encouraging for therapeutic development, as it suggests sustained benefit rather than just a temporary effect.

Oxytocin has been studied for over a decade as a potential autism therapy, with mixed results in human clinical trials. This study brings two important advances: a more translationally relevant animal model (dogs instead of mice) and a clear genetic link (SHANK3 mutation) connecting low oxytocin to specific social behavior deficits. Understanding which genetic subtypes of autism respond to oxytocin could be key to why human trials have shown inconsistent results — some patients may benefit while others don't, depending on their underlying genetics.

The abstract does not specify the number of dogs in each group, making it difficult to assess statistical power. Dogs, while more socially complex than mice, are still not humans, and maternal licking is only one facet of social behavior. The two-week treatment window is short, and long-term effects are unknown. The study focused on a single gene (SHANK3), which accounts for only a subset of autism cases. Intranasal oxytocin delivery to the brain is not fully understood even in humans.